Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03946774 · ClinicalTrials.gov registry record · NA
Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03946774 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 21 participants.
The verdict
NCT03946774, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
High protein low carbohydrate diets have become popular in recent years to help facilitate weight loss. It is controversial if these diets are associated with an increased risk of cardiovascular disease. The investigators propose to administer high and low protein shakes to participants and measure effects on circulating monocytes, immune cells critical to the development of atherosclerosis and cardiovascular disease. In order to study circulating monocytes, blood will be collected from the study participants just prior to drinking the shake, and then 1 and 4 hours after drinking the shake. In order to assess functional effects on monocytes, investigators will perform a series of assays comparing the results between individuals who drank high protein vs low protein shakes.
Interventions
- DIETARY_SUPPLEMENT Dietary protein shake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2023-05-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03946774
The ClinicalTrials.gov registry entry for NCT03946774 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dietary protein shake is the first listed.
NCT03946774 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03946774 about?
NCT03946774 is a clinical study titled "Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling". High protein low carbohydrate diets have become popular in recent years to help facilitate weight loss. It is controversial if these diets are associated with an increased risk of cardiovascular disease. The investigators propose to administer high and low protein shakes to participants and measure...
What is the current status of trial NCT03946774?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2019-10-01. Estimated completion is 2023-05-04.
What interventions are being tested in trial NCT03946774?
The interventions under investigation include: Dietary protein shake (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03946774?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.